Aging changes in skin: causes and effects

Aging, and in particular aging changes in skin, are increasingly giving cause for concern to the mankind, especially given the fact that the life expectancy is extending. Skin aging is not only a problem that concerns skin sagginess, but rather it is a complex problem caused by many factors, from immune deficiency to the lifestyle, which affects both the maintenance of the skin’s barrier function and the well-being of the stem cells that support the organ. The structure and amount of lipids in the stratum corneum changes over time, the epidermis becomes thinner, which leads to decreased barrier function of the skin. These changes also cause increased loss of transepidermal fluid. The aging-associated processes in the dermis lead to a loss of skin elasticity and a decrease in hydration. The increased levels of cytokines and histamine in the skin can cause itching and scratching, which will lead to a further increase in skin inflammation. All this can be manifested by severe xerosis, peeling and other unpleasant symptoms. It is impossible to defeat aging, but to minimize its manifestations is an achievable goal. Our experience allows us to recommend care products with pronounced nutritional and moisturizing properties, which contain panthenol, prebiotics and probiotics, sodium hyaluronate and a natural complex of glycoceramides, cholesterol and phospholipids. Panthenol has a regenerating and softening effect, nourishes and relieves irritation, contributes to the increasing strength of collagen fibres. Sodium hyaluronate is responsible for deep hydration of the skin, improving its tone and elasticity. The ceramide complex compensates for the lack of lipids and helps to retain moisture in the stratum corneum. Regular care helps to minimize xerosis, itching, skin tightness and maintain quality of life in aging patients.

1. Harvell J.D., Maibach H.I. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermatol. 1994;31(6):1015–1021. https://doi.org/10.1016/S0190-9622(94)70273-X.

2. Biniek K., Kaczvinsky J., Matts P., Dauskardt R.H. Understanding age-induced alterations to the biomechanical barrier function of human stratum corneum. J Dermatol Sci. 2015;80(2):94–101. https://doi.org/10.1016/j.jdermsci.2015.07.016.

3. Haydont V., Bernard B.A., Fortunel N.O. Age-related evolutions of the dermis: clinical signs, fibroblast and extracellular matrix dynamics. Mech Ageing Dev. 2019;177:150–156. https://doi.org/10.1016/j.mad.2018.03.006.

4. Shin J.W., Kwon S.H., Choi J.Y., Na J.I., Huh C.H., Choi H.R., Park K.C. Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci. 2019;20(9):2126. https://doi.org/10.3390/ijms20092126.

5. Lago J.C., Puzzi M.B. The effect of aging in primary human dermal fibroblasts. PLoS ONE. 2019;14(7):e0219165. https://doi.org/10.1371/journal.pone.0219165.

6. Gruber F., Kremslehner C., Eckhart L., Tschachler E. Cell aging and cellular senescence in skin aging – Recent advances in fibroblast and keratinocyte biology. Exp Gerontol. 2020;130:110780. https://doi.org/10.1016/j.exger.2019.110780.

7. Norman R.A. Xerosis and pruritus in the elderly: recognition and management. Dermatol Ther. 2003;16(3):254–259. https://doi.org/10.1046/j.1529-8019.2003.01635.x.

8. Valdes-Rodriguez R., Stull C., Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management. Drugs Aging. 2015;32(3):201–215. https://doi.org/10.1007/s40266-015-0246-0.

9. Ashida Y., Denda M. Dry environment increases mast cell number and histamine content in dermis in hairless mice. Br J Dermatol. 2003;149(2):240–247. https://doi.org/10.1046/j.1365-2133.2003.05408.x.

10. Denda M., Sato J., Tsuchiya T., Elias P.M., Feingold K.R. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol. 1998;111(5):873–878. https://doi.org/10.1046/j.1523-1747.1998.00364.x.

11. Ghadially R., Brown B.E., Sequeira-Martin S.M., Feingold K.R., Elias P.M. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995;95(5):2281–2290. https://doi.org/10.1172/JCI117919.

12. Ghadially R., Brown B.E., Hanley K., Reed J.T., Feingold K.R., Elias P.M. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol. 1996;106(5):1064–1069. https://doi.org/10.1111/1523-1747.ep12338692.

13. Ye L., Mauro T.M., Dang E., Wang G., Hu L.Z., Yu C. et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197–2201. https://doi.org/10.1111/jdv.15540.

14. Hu L., Mauro T.M., Dang E., Man G., Zhang J., Lee D. et al. Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines. J Invest Dermatol. 2017;137(6):1277–1285. https://doi.org/10.1016/j.jid.2017.01.007.

15. Bollu P.C., Sahota P. Sleep and Parkinson Disease. Mo Med. 2017;114(5):381–386. Available at: https://pubmed.ncbi.nlm.nih.gov/30228640.

16. Hepburn M., Bollu P.C., French B., Sahota P. Sleep Medicine: stroke and Sleep. Mo Med. 2018;115(6):527–532. Available at: https://pubmed.ncbi.nlm.nih.gov/30643347.

17. Denda M., Koyama J., Hori J., Horii I., Takahashi M., Hara M., Tagami H. Ageand sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res. 1993;285(7):415–417. https://doi.org/10.1007/BF00372135.

18. Man M.Q., Feingold K.R., Elias P.M. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993;129(6):728–738. Available at: https://pubmed.ncbi.nlm.nih.gov/8507075

19. Mao-Qiang M., Brown B.E., Wu-Pong S., Feingold K.R., Elias P.M. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 1995;131(7):809–816. https://doi.org/10.1001/archderm.131.7.809.

20. Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review. Nutr J. 2014;13:17. https://doi.org/10.1186/1475-2891-13-17.

21. Sasso O., Summa M., Armirotti A., Pontis S., De Mei C., Piomelli D. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. J Invest Dermatol. 2018;138(3):562–569. https://doi.org/10.1016/j.jid.2017.07.853.

22. Sakaniya L.R., Olenich I.V., Korsunskaya I.M. Sensitive skin: What is behind it and how to help patients? Medical Alphabet. 2022;(8):75–78. (In Russ.) https://doi.org/10.33667/2078-5631-2022-8-75-78.